• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶逆转录酶基因是c-Myc的直接靶点,但在细胞转化中功能并不等同。

Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.

作者信息

Greenberg R A, O'Hagan R C, Deng H, Xiao Q, Hann S R, Adams R R, Lichtsteiner S, Chin L, Morin G B, DePinho R A

机构信息

Department of Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Oncogene. 1999 Feb 4;18(5):1219-26. doi: 10.1038/sj.onc.1202669.

DOI:10.1038/sj.onc.1202669
PMID:10022128
Abstract

The telomerase reverse transcriptase component (TERT) is not expressed in most primary somatic human cells and tissues, but is upregulated in the majority of immortalized cell lines and tumors. Here, we identify the c-Myc transcription factor as a direct mediator of telomerase activation in primary human fibroblasts through its ability to specifically induce TERT gene expression. Through the use of a hormone inducible form of c-Myc (c-Myc-ER), we demonstrate that Myc-induced activation of the hTERT promoter requires an evolutionarily conserved E-box and that c-Myc-ER-induced accumulation of hTERT mRNA takes place in the absence of de novo protein synthesis. These findings demonstrate that the TERT gene is a direct transcriptional target of c-Myc. Since telomerase activation frequently correlates with immortalization and telomerase functions to stabilize telomers in cycling cells, we tested whether Myc-induced activation of TERT gene expression represents an important mechanism through which c-Myc acts to immortalize cells. Employing the rat embryo fibroblast cooperation assay, we show that TERT is unable to substitute for c-Myc in the transformation of primary rodent fibroblasts, suggesting that the transforming activities of Myc extend beyond its ability to activate TERT gene expression and hence telomerase activity.

摘要

端粒酶逆转录酶组分(TERT)在大多数原代人体细胞和组织中不表达,但在大多数永生化细胞系和肿瘤中上调。在此,我们鉴定出c-Myc转录因子是原代人成纤维细胞中端粒酶激活的直接介导因子,其通过特异性诱导TERT基因表达的能力来实现。通过使用激素诱导形式的c-Myc(c-Myc-ER),我们证明Myc诱导的hTERT启动子激活需要一个进化上保守的E盒,并且c-Myc-ER诱导的hTERT mRNA积累在没有从头蛋白质合成的情况下发生。这些发现表明TERT基因是c-Myc的直接转录靶标。由于端粒酶激活通常与永生化相关,并且端粒酶在循环细胞中起到稳定端粒的作用,我们测试了Myc诱导的TERT基因表达激活是否代表c-Myc使细胞永生化的重要机制。利用大鼠胚胎成纤维细胞合作试验,我们表明TERT在原代啮齿动物成纤维细胞转化中不能替代c-Myc,这表明Myc的转化活性超出了其激活TERT基因表达从而激活端粒酶活性的能力。

相似文献

1
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.端粒酶逆转录酶基因是c-Myc的直接靶点,但在细胞转化中功能并不等同。
Oncogene. 1999 Feb 4;18(5):1219-26. doi: 10.1038/sj.onc.1202669.
2
Direct activation of TERT transcription by c-MYC.c-MYC对端粒酶逆转录酶(TERT)转录的直接激活。
Nat Genet. 1999 Feb;21(2):220-4. doi: 10.1038/6010.
3
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.人端粒酶催化亚基(hTERT)基因启动子的克隆以及对永生化细胞和癌细胞中转录激活所必需的近端核心启动子序列的鉴定。
Cancer Res. 1999 Feb 1;59(3):551-7.
4
In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.Myc在正常细胞和肿瘤细胞中对人端粒酶(hTERT)基因启动子活性差异的体内和体外分析。
Biochem Biophys Res Commun. 1999 Sep 24;263(2):361-5. doi: 10.1006/bbrc.1999.1366.
5
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.人类端粒酶活性的调控:正常3号染色体的抑制作用可消除细胞核端粒酶逆转录酶转录本,但不影响c-Myc活性。
Cancer Res. 2001 Oct 15;61(20):7594-602.
6
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.正常与恶性人卵巢上皮细胞中人类端粒酶逆转录酶启动子调控
Cancer Res. 2001 Jul 15;61(14):5529-36.
7
Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.人端粒酶逆转录酶基因启动子区域的克隆与鉴定
Cancer Res. 1999 Feb 15;59(4):826-30.
8
Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.松杉灵芝真菌免疫调节蛋白对A549人肺腺癌细胞系端粒酶的转录介导抑制作用
Mol Carcinog. 2006 Apr;45(4):220-9. doi: 10.1002/mc.20161.
9
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.在一个代表食管鳞状细胞癌发生过程中重要基因改变的细胞模型中,人端粒酶的差异转录调控
Carcinogenesis. 2005 Nov;26(11):1879-89. doi: 10.1093/carcin/bgi153. Epub 2005 Jun 15.
10
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.金雀异黄素通过转录和翻译后机制抑制人前列腺癌细胞中的端粒酶活性。
Cancer Res. 2006 Feb 15;66(4):2107-15. doi: 10.1158/0008-5472.CAN-05-2494.

引用本文的文献

1
Telomere Reprogramming and Cellular Metabolism: Is There a Link?端粒重编程与细胞代谢:二者有关联吗?
Int J Mol Sci. 2024 Sep 29;25(19):10500. doi: 10.3390/ijms251910500.
2
Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.端粒长度作为卵巢癌患者治疗反应和生存的预测指标。
Heliyon. 2024 Jun 29;10(13):e33525. doi: 10.1016/j.heliyon.2024.e33525. eCollection 2024 Jul 15.
3
Lectins as a promising therapeutic agent for breast cancer: A review.凝集素作为一种有前途的乳腺癌治疗药物:综述。
Breast Dis. 2024;43(1):193-211. doi: 10.3233/BD-230047.
4
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers.铁(Fe3+)依赖性端粒酶再激活驱动结直肠癌。
Cancer Discov. 2024 Oct 4;14(10):1940-1963. doi: 10.1158/2159-8290.CD-23-1379.
5
InTERTwined: how promoter mutations impact BRAF-driven thyroid cancers.相互关联:启动子突变如何影响BRAF驱动的甲状腺癌
Curr Opin Endocr Metab Res. 2023 Jun;30. doi: 10.1016/j.coemr.2023.100460. Epub 2023 May 26.
6
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.端粒酶上调诱导小鼠 BrafV600E 驱动的甲状腺癌进展,并引发非端粒效应。
Mol Cancer Res. 2023 Nov 1;21(11):1163-1175. doi: 10.1158/1541-7786.MCR-23-0144.
7
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.TERT 启动子突变在不同种族、性别和癌症类型中的频率。
Oncologist. 2024 Jan 5;29(1):8-14. doi: 10.1093/oncolo/oyad208.
8
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells.NIPSNAP1 通过双重机制抑制癌细胞衰老。
J Transl Med. 2023 Jun 20;21(1):401. doi: 10.1186/s12967-023-04232-1.
9
Telomerase reactivation induces progression of mouse Braf -driven thyroid cancers without telomere lengthening.端粒酶重新激活会诱导小鼠中由Braf驱动的甲状腺癌进展,而不会使端粒延长。
bioRxiv. 2023 Jan 24:2023.01.24.525280. doi: 10.1101/2023.01.24.525280.
10
Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells.羊膜源性间充质和上皮细胞永生化的策略。
Cell Biol Int. 2022 Dec;46(12):1999-2008. doi: 10.1002/cbin.11892. Epub 2022 Aug 23.